Kilitch Drugs(I) Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Share holding
• Capital structures
• Ratio

Mar ' 23	Mar ' 22	Mar ' 21	Mar ' 20	Mar ' 19

Sources of funds

Owner's fund

Equity share capital

15.58

15.58

15.49

15.43

15.36

Share application money

0.35

0.35

0.35

1.19

1.12

Preference share capital

-

-

-

-

-

Reserves & surplus

179.99

162.09

147.09

135.02

134.60

Loan funds

Secured loans

21.86

20.33

14.71

12.51

9.36

Unsecured loans

-

-

-

-

-

Total

217.80

198.37

177.64

164.16

160.44

Uses of funds

Fixed assets

Gross block

38.16

35.78

6.94

7.67

26.18

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

23.08

21.60

-

-

18.36

Net block

15.08

14.18

6.94

7.67

7.82

Capital work-in-progress

1.31

-

-

-

-

Investments

110.29

117.38

106.50

98.08

99.65

Net current assets

Current assets, loans & advances

125.73

100.73

82.40

68.37

64.56

Less : current liabilities & provisions

34.62

33.93

18.21

9.95

11.59

Total net current assets

91.11

66.80

64.20

58.42

52.97

Miscellaneous expenses not written

-

-

-

-

-

Total

217.80

198.37

177.64

164.16

160.44

Notes:

Book value of unquoted investments

71.10

116.37

70.10

70.27

47.70

Market value of quoted investments

39.20

-

36.40

27.81

28.42

Contingent liabilities

0.76

0.76

0.76

-

5.57

Number of equity sharesoutstanding (Lacs)

155.82

155.82

154.94

153.55

153.55